Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bria-OTS (BC1) in Metastatic Recurrent Breast Cancer
NCT06471673Phase 2Recruiting
- Sponsor
- BriaCell Therapeutics Corp.
- Start
- May 2024
- Primary completion
- Apr 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of Bria-OTS in breast cancer, sponsored by BriaCell Therapeutics Corp.. Started May 2024; status: recruiting.
02
Drugs
Bria-OTS
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06471673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06471673.